Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 0409-8183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 0409-8183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Potassium 01)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) single-dose vial label. The injection is for intravenous use and must be diluted before administration. The label includes storage, usage, and safety information, and lists Hospira, Inc. as the distributor located in Lake Forest, IL.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) in a 20 mL single-dose vial carton label from Hospira, Inc. The label includes instructions indicating the product must be diluted prior to intravenous use. Contains 25 vials per package and displays the NDC 0409-8183-25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.